All times are listed in CET (Central European Time)

Browsing Over 190 Presentations

Sort By
AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC Industry Satellite Symposium

Welcome and introduction

Lecture Time
16:10 - 16:15
Speakers
  • M. Reck (Grosshansdorf, Germany)
Session Name
AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
16:10 - 17:40
Authors
  • M. Reck (Grosshansdorf, Germany)
AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC Industry Satellite Symposium

The treatment paradigm for unresectable stage III NSCLC: Exploring the growing evidence base

Lecture Time
16:15 - 16:30
Speakers
  • M. Gottfried (Kefar Sava, Israel)
Session Name
AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
16:10 - 17:40
Authors
  • M. Gottfried (Kefar Sava, Israel)
AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC Industry Satellite Symposium

Treating 1L ES-SCLC with immuno-oncology: A clinical case study

Lecture Time
17:15 - 17:30
Speakers
  • A. Addeo (Geneva, Switzerland)
Session Name
AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
16:10 - 17:40
Authors
  • A. Addeo (Geneva, Switzerland)
AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC Industry Satellite Symposium

The evolving role of immuno-oncology treatment for ES-SCLC

Lecture Time
17:00 - 17:15
Speakers
  • E. Arriola (Barcelona, Spain)
Session Name
AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
16:10 - 17:40
Authors
  • E. Arriola (Barcelona, Spain)
AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC Industry Satellite Symposium

Live panel discussion and audience Q&A

Lecture Time
17:30 - 17:55
Speakers
  • A. Speakers (, Switzerland)
Session Name
AstraZeneca - Immuno-oncology treatment paradigms for first-line ES SCLC and unresectable stage III NSCLC
Room
Channel 1
Date
Thu, 25.03.2021
Time
16:10 - 17:40
Authors
  • A. Speakers (, Switzerland)
Brain metastases are not all the same Educational session

Surgical indications and timing

Lecture Time
16:55 - 17:10
Speakers
  • M. De Praeter (Edegem, Belgium)
Session Name
Brain metastases are not all the same
Room
Channel 2
Date
Fri, 26.03.2021
Time
16:55 - 17:55
Authors
  • M. De Praeter (Edegem, Belgium)
Brain metastases are not all the same Educational session

State of the art and future perspective from radiation oncology

Lecture Time
17:10 - 17:25
Speakers
  • U. Ricardi (Torino, Italy)
Session Name
Brain metastases are not all the same
Room
Channel 2
Date
Fri, 26.03.2021
Time
16:55 - 17:55
Authors
  • U. Ricardi (Torino, Italy)
Brain metastases are not all the same Educational session

Targeted therapy for oncogene addicted NSCLC

Lecture Time
17:25 - 17:40
Speakers
  • J. Yang (Taipei City, Taiwan)
Session Name
Brain metastases are not all the same
Room
Channel 2
Date
Fri, 26.03.2021
Time
16:55 - 17:55
Authors
  • J. Yang (Taipei City, Taiwan)
Brain metastases are not all the same Educational session

Systemic treatment for non-oncogene addicted NSCLC

Lecture Time
17:40 - 17:55
Speakers
  • L. Hendriks (Maastricht, Netherlands)
Session Name
Brain metastases are not all the same
Room
Channel 2
Date
Fri, 26.03.2021
Time
16:55 - 17:55
Authors
  • L. Hendriks (Maastricht, Netherlands)
Bristol Myers Squibb - In-the-know with I-O: Clinical conversations and considerations for thoracic cancer treatments Industry Satellite Symposium

Live Q&A

Lecture Time
17:25 - 17:40
Speakers
  • A. Speakers (, Switzerland)
Session Name
Bristol Myers Squibb - In-the-know with I-O: Clinical conversations and considerations for thoracic cancer treatments
Room
Channel 2
Date
Thu, 25.03.2021
Time
16:10 - 17:40
Authors
  • A. Speakers (, Switzerland)
Bristol Myers Squibb - In-the-know with I-O: Clinical conversations and considerations for thoracic cancer treatments Industry Satellite Symposium

Welcome and introduction

Lecture Time
16:10 - 16:20
Speakers
  • R. Juergens (Hamilton, ON, Canada)
Session Name
Bristol Myers Squibb - In-the-know with I-O: Clinical conversations and considerations for thoracic cancer treatments
Room
Channel 2
Date
Thu, 25.03.2021
Time
16:10 - 17:40
Authors
  • R. Juergens (Hamilton, ON, Canada)
Bristol Myers Squibb - In-the-know with I-O: Clinical conversations and considerations for thoracic cancer treatments Industry Satellite Symposium

Expert opinion on I-O-based treatment approaches for metastatic NSCLC

Lecture Time
16:20 - 16:55
Speakers
  • S. Peters (Lausanne, Switzerland)
Session Name
Bristol Myers Squibb - In-the-know with I-O: Clinical conversations and considerations for thoracic cancer treatments
Room
Channel 2
Date
Thu, 25.03.2021
Time
16:10 - 17:40
Authors
  • S. Peters (Lausanne, Switzerland)
  • R. Juergens (Hamilton, ON, Canada)